| Metric | Q1 2025 | Q4 2024 | Q1 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $266M | — | — | — | — |
| Op. Income | $58M | — | — | — | — |
| Gross Margin | 53.0% | — | — | — | — |
| Net Margin | 13.2% | — | — | — | — |
| EPS (Diluted) | $1.22 | — | — | — | — |
| Free Cash Flow | $54M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $266M |
| Cost of Revenue | $125M |
| GROSS PROFIT | $141M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $30M |
| SG&A Expenses | $30M |
| Other Expenses | $53M |
| Operating Expenses | $83M |
| Cost & Expenses | $208M |
| OPERATING INCOME | $58M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | -$9M |
| INCOME BEFORE TAX | $49M |
| Income Tax Expense | $14M |
| Net Income from Continuing Ops | $35M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $53M |
| EBIT | $59M |
| EBITDA | $112M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $266M |
| Cost of Revenue | $125M |
| GROSS PROFIT | $141M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $30M |
| SG&A Expenses | $30M |
| Other Expenses | $53M |
| Operating Expenses | $83M |
| Cost & Expenses | $208M |
| OPERATING INCOME | $58M |
| Interest Income | $0 |
| Interest Expense | $10M |
| Other Income/Expenses | -$9M |
| INCOME BEFORE TAX | $49M |
| Income Tax Expense | $14M |
| Net Income from Continuing Ops | $35M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $53M |
| EBIT | $59M |
| EBITDA | $112M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $35M |
| Depreciation & Amortization | $53M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | -$5M |
| Other Non-Cash Items | $1M |
| Change in Working Capital | $33M |
| OPERATING CASH FLOW | $119M |
| Capital Expenditure | -$65M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $19M |
| NET CASH FROM INVESTING | -$46M |
| Net Debt Issuance | $2M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$1M |
| NET CASH FROM FINANCING | $1M |
| FREE CASH FLOW | $54M |
| Net Change in Cash | $74M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $148M |
| Short-Term Investments | $0 |
| Net Receivables | $163M |
| Inventory | $0 |
| Other Current Assets | $54M |
| TOTAL CURRENT ASSETS | $365M |
| PP&E (Net) | $1.2B |
| Goodwill | $746M |
| Intangible Assets | $992M |
| Long-Term Investments | $1M |
| Tax Assets | $0 |
| Other Non-Current Assets | $164M |
| TOTAL NON-CURRENT ASSETS | $3.1B |
| TOTAL ASSETS | $3.4B |
| Account Payables | $97M |
| Short-Term Debt | $4M |
| Deferred Revenue | $21M |
| Other Current Liabilities | $79M |
| TOTAL CURRENT LIABILITIES | $201M |
| Long-Term Debt | $1.1B |
| Deferred Revenue NC | $130M |
| Deferred Tax Liabilities | $353M |
| Other Non-Current Liabilities | $143M |
| TOTAL NON-CURRENT LIABILITIES | $1.8B |
| TOTAL LIABILITIES | $2.0B |
| Common Stock | $1.8B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | -$328M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.4B |
| Minority Interest | $15M |
| TOTAL EQUITY | $1.5B |
| TOTAL LIABILITIES & EQUITY | $3.4B |
| Total Debt | $1.1B |
| Net Debt | $996M |
